" class="no-js "lang="en-US"> Huma - Medtech Alert
Wednesday, March 22, 2023

Breaking News

Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Dupixent® (dupilumab) Approved by European Commission as First and Only Targeted Medicine for Children as Young as Six Months Old with Severe Atopic Dermatitis Gamida Cell Announces Changes to Board of Directors Newron Reports Topline Results From All Patients in Study Evaluating Evenamide as Add-on Therapy for Treatment-Resistant Schizophrenia Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer TFS HealthScience Expands Operations into Israel, With Focus on Continuous, Rapid International Expansion
Huma | Pharmtech Focus

Huma

About Huma

Huma

Huma is on a journey to use data to deliver good health for all. By partnering with science, technology, and healthcare professionals we use these insights to transform care for people everywhere.

Related Story

Diseases

 Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease | MTA

Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease

February 8 2023

Huma Therapeutics, a leading global digital health company, today announced a partnership with Camden Health […]

Clinical Trials

 Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis | PTF

Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis

January 9 2023

Huma Therapeutics, a leading global digital health company, today announced that it has acquired Alcedis […]

Appointments

 Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions | Pharmtech Focus|Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions | Pharmtech Focus

Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions

August 15 2022

Gune joins Huma to drive further commercial adoption of the company’s digital health platforms in […]

COVID-19

 Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS | Pharmtech Focus

Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS

June 24 2022

Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]

Health Apps

 Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care | Pharmtech Focus

Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care

March 23 2022

Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research […]

Fundraising

 Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research | Pharmtech Focus

Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research

May 12 2021

Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately […]

Diseases

 Huma and RARE-X Partner to Accelerate Research for 9

Huma and RARE-X Partner to Accelerate Research for 9,500 Rare Diseases

April 15 2021

Huma, Europe’s fastest-growing health technology company, is partnering with the non-profit patient advocacy group RARE-X, which runs […]